Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innoviva (INVA) Revenue (2016 - 2026)

Innoviva filings provide 15 years of Revenue readings, the most recent being $107.8 million for Q3 2025.

  • On a quarterly basis, Revenue rose 20.44% to $107.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $209.8 million, a 9.33% increase, with the full-year FY2025 number at $411.3 million, up 14.67% from a year prior.
  • Revenue hit $107.8 million in Q3 2025 for Innoviva, up from $100.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $107.8 million in Q3 2025 to a low of $491000.0 in Q1 2025.
  • Median Revenue over the past 5 years was $1.2 million (2022), compared with a mean of $30.4 million.
  • Biggest five-year swings in Revenue: crashed 98.67% in 2022 and later soared 10093.67% in 2024.
  • Innoviva's Revenue stood at $989000.0 in 2021, then grew by 6.27% to $1.1 million in 2022, then soared by 45.39% to $1.5 million in 2023, then decreased by 19.18% to $1.2 million in 2024, then skyrocketed by 8628.74% to $107.8 million in 2025.
  • The last three reported values for Revenue were $107.8 million (Q3 2025), $100.3 million (Q2 2025), and $491000.0 (Q1 2025) per Business Quant data.